TIGIT antibody (Extracellular Domain)
Quick Overview for TIGIT antibody (Extracellular Domain) (ABIN6992247)
Target
See all TIGIT AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- Extracellular Domain
-
Purification
- TIGIT Antibody is supplied as protein A purified IgG1.
-
Immunogen
- TIGIT antibody was raised against the extracellular domain of human TIGIT
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
TIGIT antibody can be used for immunohistochemistry starting at 2 μ,g/mL. For immunofluorescence start at 1 μ,g/mL. For flow cytometry at 1 μ,g/mL. For immunocytochemistry at 1 μ,g/mL. For Western blot at 1 μ,g/mL.
Antibody validated: Western Blot in human samples, Immunohistochemistry in human samples, Immunocytochemistry in human samples, Immunofluorescence in human samples and Flow Cytometry in human samples. All other applications and species not yet tested. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- TIGIT Antibody is supplied in PBS containing 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,4 °C
-
Storage Comment
- TIGIT antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))
-
Alternative Name
- TIGIT
-
Background
- TIGIT Antibody: The T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a member of the PVR (poliovirus receptor) family of immunoglobin proteins. It is expressed on several classes of T cells including follicular B helper T cells (TFH). TIGIT has been shown to bind PVR with high affinity, this binding is thought to assist interactions between TFH and dendritic cells to regulate T cell dependent B cell responses (1). Similar to other immune checkpoint proteins such as PD-1, TIGIT is upregulated on exhausted T cells in chronic viral infections and cancer. Blockade of both TIGIT and PD-1 pathways leads to tumor rejection in mice suggesting that it may be of therapeutic use against cancer (2).
-
Molecular Weight
-
Predicted: 26 kDa
Observed: 47 kDa -
Gene ID
- 201633
-
NCBI Accession
- NP_776160
-
UniProt
- Q495A1
-
Pathways
- Cancer Immune Checkpoints
Target
-